Prime Medicine, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $1,154 | $856 | $838 | $1,225 |
Gross Profit | 1,154 | -1,000 | 838 | -42,765 |
EBITDA | -40,324 | -47,266 | -44,203 | -48,701 |
EBIT | -42,109 | -49,122 | -46,079 | -50,582 |
Net Income | -42,109 | -49,122 | -46,079 | -50,582 |
Net Change In Cash | 1,154 | 856 | 838 | 1,225 |
Free Cash Flow | -41,092 | -42,924 | -37,546 | -35,286 |
Cash | 47,451 | 64,106 | 63,032 | 71,396 |
Basic Shares | 177,224 | 177,096 | 148,758 | 160,503 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,632 | $2,983 | $0 | $5,210 |
Gross Profit | -2,689 | 2,983 | -4,653 | -12,014 |
EBITDA | -195,758 | -189,754 | -186,639 | -120,545 |
EBIT | -201,142 | -195,882 | -191,292 | -122,769 |
Net Income | -201,142 | -195,882 | -198,133 | -121,821 |
Net Change In Cash | 4,632 | 2,983 | 0 | 5,210 |
Cost of Revenue | 2,571 | |||
Free Cash Flow | -167,095 | -130,159 | -174,136 | -147,922 |
Cash | 63,032 | 182,476 | 41,574 | 187,620 |
Basic Shares | 148,758 | 118,600 | 90,969 | 97,209 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.24 |
2026-03-31 | -$0.28 |
2025-12-31 | -$0.24 |
2025-09-30 | -$0.32 |